Monthly Archives: October 2004
CAT SPRING – Lloyd Klaus is a talented woodworker, with beautiful steamer trunks and lazy Susans his specialties.
Once a commercial sawmill operator, he has scaled down his sawmill duties to simply providing for a personal woodworking supply; breaking away from time to time to assist a friend or neighbor.
Each year, more than 11,000 people will become paralyzed in the United States. It happens in a split second, but it changes lives forever.
Researchers are constantly looking for ways to reverse the condition. Now there is a promising discovery that could put them on the fast track.
Clinical trials that could ultimately lead to repair of spinal cord injuries are scheduled to begin within three years at University College London, following the arrival of an internationally-renowned research team at the university’s Institute of Neurology. UCL today announced the arrival of Professor Geoff Raisman, who will be the first Director of the new Spinal Repair Unit, and his team from the National Institute for Medical Research (NIMR), at a press conference to launch Advancing London’s Global University – the Campaign for UCL, UCL’s development plan for the next decade.
Human trials of a technique with the potential to repair spinal cord injuries are set to start within three years, experts said today.
The work, which could help thousands of disabled people regain movement, will be carried out at University College London’s new Spinal Repair Unit.
The plans were outlined today as UCL launched a £300 million fundraising campaign to boost work across the university.
With only 29 days left until Election Day, democratic presidential nominee Sen. John Kerry and actor-turned-activist Michael J. Fox discussed the issue of stem cell research with an enthusiastic crowd Monday morning at Winnacunnet High School in Hampton, N.H.
In August of 2001 President Bush announced that the federal government would only support restricted study of stem cells.
(Reuters) – Geron Corp. (GERN.O:Research) said on Tuesday it was granted a patent on a type of human embryonic stem cell growth technology, sending shares of the Biotechnology company up 10 percent.
Human embryonic stem cells are versatile cells that scientists hope to manipulate into various cells and tissues to treat a variety of diseases.
Newswise — Two studies presented at the 129th annual meeting of the American Neurological Association in Toronto describe substances that could help protect nerve cells in the spinal cord, either following injury or in neurodegenerative diseases.
One study describes a “growth factor” that can help damaged nerve fibers to grow back toward their original targets. Another demonstrates that an antibiotic called minocycline can protect nerve cells from dying when their nerve fibers have been damaged. Both studies have implications
The body attempts to heal a damaged spinal cord in much the same way it repairs skin after simple cuts and scrapes, an insight that may lead to new treatments for the thousands of people paralyzed each year because of spinal cord injuries, say scientists at the University of Florida Health Science Center.
Writing in the current Journal of Neuroscience, scientists deliver the first-ever glimpse of how thousands of genes swing into action during the weeks and months after a spinal cord injury, suggesting there may be many more chances to treat the injury than commonly thought.
MONDAY, Oct. 4 (HealthDayNews) — Early magnetic resonance imaging (MRI) of spinal cord injuries can help doctors identify patients who would benefit from surgery, says a Toronto Western Hospital study.
“The extent of spinal cord compression on MRI at the initial time of injury was strongly associated with the initial degree of neurological Impairment and was highly predictive of neurological outcome in long-term follow-up,”
Estimates vary, but the generally accepted range is between 183,000 and 230,000 persons are alive today in the U.S. with SCI.